title: Research goals for folate and related B vitamin in Europe.
abstract: In the past decade, the understanding of folate bioavailability, metabolism and related health issues has increased, but several problems remain, including the difficulty of delivering the available knowledge to the populations at risk. Owing to the low compliance of taking folic acid supplements, for example, among women of child-bearing age who could lower the risk of having a baby with a neural tube defect, food-based strategies aimed at increasing the intake of folate and other B-group vitamins should be a priority for future research. These should include the development of a combined strategy of supplemental folate (possibly with vitamin B(12)), biofortification using engineered plant-derived foods and micro-organisms and food fortification for increasing folate intakes in the general population. Currently, the most effective population-based strategy to reduce NTDs remains folic acid fortification. However, the possible adverse effect of high intakes of folic acid on neurologic functioning among elderly persons with vitamin B(12) deficiency needs urgent investigation. The results of ongoing randomized controlled studies aimed at reducing the prevalence of hyperhomocysteinemia and related morbidity must be available before food-based total population approaches for treatment of hyperhomocysteinemia can be recommended. Further research is required on quantitative assessment of folate intake and bioavailability, along with a more thorough understanding of physiological, biochemical and genetic processes involved in folate absorption and metabolism.
authors.affiliation: Institute of Food Research, Norwich Research Park, Colney, UK. paul.finglas@bbsrc.ac.uk
authors.forename: P M
authors.initials: PM
authors.lastname: Finglas
authors.forename: K
authors.initials: K
authors.lastname: de Meer
authors.forename: A
authors.initials: A
authors.lastname: Molloy
authors.forename: P
authors.initials: P
authors.lastname: Verhoef
authors.forename: K
authors.initials: K
authors.lastname: Pietrzik
authors.forename: H J
authors.initials: HJ
authors.lastname: Powers
authors.forename: D
authors.initials: D
authors.lastname: van der Straeten
authors.forename: M
authors.initials: M
authors.lastname: Jägerstad
authors.forename: G
authors.initials: G
authors.lastname: Varela-Moreiras
authors.forename: T
authors.initials: T
authors.lastname: van Vliet
authors.forename: R
authors.initials: R
authors.lastname: Havenaar
authors.forename: J
authors.initials: J
authors.lastname: Buttriss
authors.forename: A J A
authors.initials: AJ
authors.lastname: Wright
mesh_terms: D001682:Biological Availability; D005492:Folic Acid / Q000008:administration & dosage* / Q000378:metabolism / Q000493:pharmacokinetics*; D005524:Food Technology; D005527:Food, Fortified; D006801:Humans; D020138:Hyperhomocysteinemia / Q000517:prevention & control*; D007408:Intestinal Absorption; D009436:Neural Tube Defects / Q000517:prevention & control*; D014805:Vitamin B 12 / Q000008:administration & dosage; D014803:Vitamin B Complex / Q000008:administration & dosage* / Q000378:metabolism / Q000493:pharmacokinetics*
chemical_list: D014803:Vitamin B Complex; D005492:Folic Acid; D014805:Vitamin B 12